Nottingham, United Kingdom

Thomas Michael Waugh

USPTO Granted Patents = 1 

 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Michael Waugh: Innovator in Inflammatory Disease Treatment

Introduction

Thomas Michael Waugh is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the treatment of inflammatory diseases. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Waugh holds a patent for "Itaconic acid derivatives and uses thereof in treating an inflammatory disease or a disease associated with an undesirable immune response." This invention relates to compounds of a specific formula and their application in treating or preventing inflammatory diseases. The compounds are designed to target undesirable immune responses, showcasing Waugh's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Thomas Michael Waugh has been associated with Sitryx Therapeutics Limited, where he has played a pivotal role in research and development. His work has not only contributed to the company's portfolio but has also positioned him as a key figure in the field of therapeutic innovations.

Collaborations

Waugh has collaborated with notable colleagues, including Michael Liam Cooke and David Cousin. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in their respective fields.

Conclusion

Thomas Michael Waugh's contributions to the treatment of inflammatory diseases through innovative patenting exemplify his dedication to improving healthcare. His work continues to inspire future innovations in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…